Technology Networks
Waters Corporation and UCLA to Convene Leading Life Scientists
Will present latest research at applications of time of flight mass spectrometry conference September 13-15.
Novozymes Showcases Biopharmaceutical Solutions at BioProcess International 2010
The Company plans to feature its range of regulatory compliant, recombinant and animal-free products and technologies at the annual conference.
MorphoSys Initiates Program Against Drug-Resistant MRSA Infections
MorphoSys secures access to innovative targets through in-licensing and collaboration agreement with Absynth biologics.
SemBiosys Issued Key U.S. Patent for the Production of Apolipoproteins in Plants
The patent is key to successfully commercializing plant made and seed expressed Apo AI.
Novozymes Announces Master File for Recombinant Albumin
The dossier, containing information on the manufacture and safety of albucult, can help support the medical devices and drug formulation applications.
Natural System for Eliminating Salt May Point to new Antihypertensives
A study of the body system that deals with Americans' love affair with salt may yield more insight into why so many end up hypertensive and how to better treat them.
Drug Analysis 2010 - Antwerp, Belgium
21 September 2010 - 24 September 2010

This international symposium is organized by the Belgian Society of Pharmaceutical Sciences (BSPS) since 1983 and will cover all aspects of pharmaceutical and biomedical analysis, including emerging domains, such as ‘omics’, process analytical technology and green analysis.
2nd Annual Population PK-PD
23 September 2010 - 24 September 2010

Integrating advanced PK/PD models with systems biology to make early impacts in the decision making process.
This annual marcus evans conference will be focusing on overcoming these challenges by understanding from a technology and concept perspective on how to marry the distinct practices of PKPD and systems biology.
BIOTECHNICA Hannover, Germany
05 October 2010 - 07 October 2010

BIOTECHNICA is one of Europe's top annual meeting places for the biotech and life science industry. Here you meet target groups you would never reach at a conventional trade fair thanks to an extensive conference programme that attracts a high calibre of visitors.
Contract Science Writer
Alto Marketing
Contract Science Writer 3 month fixed term - 2 or 3 days per week
Computer Scientists in Genomics
Institute for Molecular Biology
The newly founded Institute for Molecular Biology (IMB) is an Excellence Center for Life Science, funded by the Boehringer Ingelheim Foundation, and located in Mainz, Germany.
Mass Spectrometry Scientist (#1753)
Roswell Park Cancer Institute
The Roswell Park Cancer Institute Division of Health Research Inc. is seeking a full-time Mass Spectrometry Scientist to develop and validate analytical assays for cancer drugs and their metabolites in biological matrices such as plasma, urine, cells and tissues using LC-MS, LC-MS/MS, HPLC and/or UPLC.
Post-doctoral Scientist
University of North Carolina
The UNC Metabolomics Laboratory has an immediate opening for a recent Ph.D. interested in translational metabolomics studies on chemical and environmental toxicity.
Protein NMR/Biophysics Research Associate (BS/MS)
Novartis Institutes for BioMedical Research
We are committed to discovering innovative medicines to cure disease and improve human health. By hiring the best academic, biotech, and pharmaceutical trained scientists, we have fostered an atmosphere for drug discovery where innovation is rewarded.
Senior Account Manager/Account Director
Alto Marketing
The best career move for a well-connected marketing professional with real leadership ability and drive!
Specificity of small molecule inhibitors for deubiquitinating enzymes in living cells assessed by activity-based proteomics
*Henry Wellcome Building for Molecular Physiology, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK, #Progenra Inc, Malvern, PA 19355, USA

Small molecular compounds (PR-619 and P22077) was assessed for their abilities to inhibit DUB function in crude extracts and in cells. Activity-based profiling combined with quantitative mass spectrometry revealed the inhibitory capacity of a broad range of DUBs by the PR-619, whereas P22077 showed specificity towards subsets of DUBs including USP7 in cells. Our results demonstrate the usefulness of activity-based quantitative proteomics to monitor inhibition of endogenous DUBs in vivo.
Capture Compounds towards a targeted reduction of proteome complexity
caprotec bioanalytics GmbH

Capture Compound Mass Spectrometry (CCMS) enables the enrichment of proteins based on their functionality. CCMS is commercialized as kits for research applications and in collaborations with pharmaceutical companies. The focus is on investigating mechanisms of drug action and avoidance of toxic effects of small molecule drugs.
  
Preclinical and Clinical Use of Caspase-cleaved CK18 as a Serum Biomarker for Tumor Cell Apoptosis

Stig Linder, Group Leader, Karolinska Institute, speaking at European Biomarkers Summit 2009
Biomarker Qualification: Europe is ready, are you?

Patricia Hurley, Division Head, ERA Consulting, speaking at European Biomarkers Summit 2009
Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects
Select Biosciences Ltd

This innovative & analytical report can be used to assess market trends & appraise the potential of new antibodies & therapeutic proteins. It provides perspective to gain an in-depth understanding of the marketplace, players, products & leading technologies driving the field.
Multiplexed Diagnostics 2010
Select Biosciences Ltd

The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points.